Invention Grant
- Patent Title: Lisinopril formulations
-
Application No.: US16822412Application Date: 2020-03-18
-
Publication No.: US10940177B2Publication Date: 2021-03-09
- Inventor: Gerold L. Mosher , David W. Miles
- Applicant: Silvergate Pharmaceuticals Inc.
- Applicant Address: US CO Greenwood Village
- Assignee: Silvergate Pharmaceuticals Inc.
- Current Assignee: Silvergate Pharmaceuticals Inc.
- Current Assignee Address: US CO Greenwood Village
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K38/05
- IPC: A61K38/05 ; A61K47/12 ; A61K47/02 ; A61K9/00 ; A61K47/26 ; A61K31/401 ; A61K38/00 ; A61K45/06
Abstract:
Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
Public/Granted literature
- US20200237851A1 LISINOPRIL FORMULATIONS Public/Granted day:2020-07-30
Information query
IPC分类:
